Osman Selçuk Duysak

Dr. Osman Selçuk Duysak

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
SUSaime Sundus sundus Uygun
Saime Sundus sundus Uygun
HDHatice Türk Dağı
Hatice Türk Dağı
GAGülsüm Alkan
Gülsüm Alkan
OUOnur Ural
Onur Ural
BOBarış Otlu
Barış Otlu
MKMurat Konak
Murat Konak
Ralstonia pickettii is an opportunistic Gram-negative bacterium associated with healthcare-associated infections, particularly in premature infants and other immunocompromised or critically ill patients. This study aimed to investigate a neonatal intensive care unit outbreak of Ralstonia pickettii bacteremia by describing the clinical characteristics of affected infants, identifying the environmental source, and evaluating the genetic relatedness between clinical and environmental isolates. Hospital records from January 2023 through November 2025 were reviewed; the nine included cases occurred between February 2024 and October 2025. Demographic, clinical, and laboratory data were reviewed. Environmental sampling was performed to identify the source of contamination. Genetic relatedness between clinical and environmental isolates was evaluated using arbitrarily primed polymerase chain reaction (AP-PCR), and the molecular findings were interpreted together with microbiological and epidemiological data. This study was initially designed as a retrospective clinical review and was subsequently expanded to include an outbreak investigation after three temporally clustered cases were identified in October 2025. The outbreak involved nine neonates with Ralstonia pickettii bacteremia. Environmental investigation identified Ralstonia pickettii in both opened and unopened sterile distilled water samples. Clinical and environmental isolates demonstrated highly similar AP-PCR banding patterns, supporting genetic relatedness when interpreted together with microbiological and epidemiological findings. Following removal of the contaminated source and implementation of infection control measures, no additional R. pickettii bacteremia cases were identified. Overall mortality was 44.4%, whereas only one death (11.1%) was considered attributable to Ralstonia pickettii bacteremia. Ralstonia pickettii can cause healthcare-associated outbreaks in neonatal intensive care units. Integration of microbiological, environmental, epidemiological, and molecular findings may facilitate timely outbreak source identification and implementation of effective infection control measures.

24 August 2026 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
MKMurat Konak
Murat Konak
BBBanu Bozkurt
Banu Bozkurt
GCGülay Ceylaner
Gülay Ceylaner
MCMuserref Kasap Cuceoglu
Muserref Kasap Cuceoglu
FÖFatih Mehmet Akif Özdemir
Fatih Mehmet Akif Özdemir
SUSaime Sundus sundus Uygun
Saime Sundus sundus Uygun
Neonatal-onset Aicardi–Goutières syndrome (AGS) is a rare monogenic type I interferonopathy that may mimic congenital infection and can present

19 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
SUSaime Sundus sundus Uygun
Saime Sundus sundus Uygun
NÇNihal Çömez
Nihal Çömez
ODOsman Selçuk Duysak
Osman Selçuk Duysak
EKEvrim Kilicli
Evrim Kilicli
MKMurat Konak
Murat Konak
HSHanifi Soylu
Hanifi Soylu
Background/Objectives: The decision to administer surfactant therapy to preterm newborns is typically based on clinical respiratory findings, oxygen requirements, and the level of respiratory support. The aim of this study was to assess the association of admission complete blood count parameters and derived systemic inflammatory indices with surfactant administration within the first 24 h of life in preterm infants born at ≤32 weeks of gestation, and to evaluate their discriminative performance. Methods: This single-center, retrospective observational cohort study included 100 preterm infants with a gestational age of ≤32 weeks who were admitted to the neonatal intensive care unit between 1 January 2025 and 31 March 2026. The results of the initial complete blood count and blood gas analysis, obtained as part of routine clinical care at admission, were recorded. Systemic inflammatory indices, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), red cell distribution width-to-platelet ratio (RPR), systemic immune-inflammation index (SII), and mean platelet volume-to-platelet ratio (MPV/PLT), were calculated from the complete blood count results. The primary outcome was surfactant administration within the first 24 h of life. Associated factors were evaluated using logistic regression analysis, and the discriminative performance of continuous variables was assessed using receiver operating characteristic (ROC) curve analysis. Results: Surfactant was administered to 45 infants (45%) within the first 24 h of life. Infants who received surfactant had lower gestational ages, birth weights, 1- and 5 min Apgar scores, partial pressure of carbon dioxide (PCO2), hemoglobin levels, and hematocrit values. No significant differences were observed between groups in NLR, PLR, MLR, RPR, SII, or MPV/PLT. In multivariable analysis, lower gestational age (OR = 0.65; 95% CI: 0.50–0.84; p = 0.001), small-for-gestational-age (SGA) status (OR = 4.61; 95% CI: 1.25–16.91; p = 0.021), and lower 1 min Apgar score (OR = 0.67; 95% CI: 0.46–0.96; p = 0.031) were independently associated with early surfactant administration. Hemoglobin was not independently associated with early surfactant administration after adjustment. In the ROC analysis, the AUC values were 0.804 for birth weight, 0.776 for gestational age, 0.694 for hemoglobin, 0.677 for hematocrit, and 0.640 for PCO2. Conclusions: Lower gestational age, SGA status, and lower 1 min Apgar score were independently associated with early surfactant administration. No significant associations were observed between the evaluated complete blood count-derived inflammatory indices and early surfactant administration. Although hemoglobin and hematocrit levels differed between groups, hemoglobin was not independently associated with the outcome after adjustment. ROC analysis provided descriptive estimates of the discriminative performance of gestational age, birth weight, hemoglobin, hematocrit, and PCO2.

10 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ODOsman Selçuk Duysak
Osman Selçuk Duysak
MKMurat Konak
Murat Konak
MKMuhammed Yaşar Kılınç
Muhammed Yaşar Kılınç
SUSaime Sundus sundus Uygun
Saime Sundus sundus Uygun
HSHanifi Soylu
Hanifi Soylu
Objectives: Diuretics are frequently used in bronchopulmonary dysplasia (BPD), yet evidence describing their short-term physiological effects remains limited. This study aimed to describe early changes in respiratory support parameters and safety outcomes following combined oral spironolactone and hydrochlorothiazide (SP/HCTZ) therapy in preterm infants with BPD. Methods: A retrospective, single-center before–after observational study was conducted. Preterm infants diagnosed with BPD who initiated SP/HCTZ therapy were included. Respiratory parameters (FiO2, PEEP, and flow rate) and serum electrolytes were compared between Day 1 (initiation) and Day 3 of treatment. A predefined clinical response was defined as either a ≥10% reduction in FiO2 or a step-down in respiratory support modality. Results: Fifty-six infants (mean gestational age 27.7 ± 2.3 weeks) were analyzed. After 72 h of SP/HCTZ therapy, mean FiO2 decreased from 26.2 ± 6.3% to 22.4 ± 3.4% (p < 0.001). Significant reductions were also observed in PEEP and cannula flow rates (p = 0.004 and p = 0.003, respectively). Overall, 39 infants (69.6%) met the predefined clinical response criteria. The prevalence of hyponatremia (Na < 133 mmol/L) increased from 7.1% at baseline to 25.0% on Day 3 (p = 0.039). Conclusions: Initiation of SP/HCTZ was temporally associated with short-term reductions in respiratory support parameters; however, these findings should be interpreted as associations rather than treatment effects. Given the increased frequency of hyponatremia by Day 3, close electrolyte monitoring appears warranted during the early phase of therapy.